Emergency hospitalizations for unsupervised prescription medication ingestions by young children - PubMed (original) (raw)

Multicenter Study

. 2014 Oct;134(4):e1009-16.

doi: 10.1542/peds.2014-0840. Epub 2014 Sep 15.

Affiliations

Multicenter Study

Emergency hospitalizations for unsupervised prescription medication ingestions by young children

Maribeth C Lovegrove et al. Pediatrics. 2014 Oct.

Abstract

Background: Emergency department visits and subsequent hospitalizations of young children after unsupervised ingestions of prescription medications are increasing despite widespread use of child-resistant packaging and caregiver education efforts. Data on the medications implicated in ingestions are limited but could help identify prevention priorities and intervention strategies.

Methods: We used nationally representative adverse drug event data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project and national retail pharmacy prescription data from IMS Health to estimate the frequency and rates of emergency hospitalizations for unsupervised prescription medication ingestions by young children (2007-2011).

Results: On the basis of 1513 surveillance cases, 9490 estimated emergency hospitalizations (95% confidence interval: 6420-12,560) occurred annually in the United States for unsupervised prescription medication ingestions among children aged <6 years from 2007 through 2011; 75.4% involved 1- or 2-year old children. Opioids (17.6%) and benzodiazepines (10.1%) were the most commonly implicated medication classes. The most commonly implicated active ingredients were buprenorphine (7.7%) and clonidine (7.4%). The top 12 active ingredients, alone or in combination with others, were implicated in nearly half (45.0%) of hospitalizations. Accounting for the number of unique patients who received dispensed prescriptions, the hospitalization rate for unsupervised ingestion of buprenorphine products was significantly higher than rates for all other commonly implicated medications and 97-fold higher than the rate for oxycodone products (200.1 vs 2.1 hospitalizations per 100,000 unique patients).

Conclusions: Focusing unsupervised ingestion prevention efforts on medications with the highest hospitalization rates may efficiently achieve large public health impact.

Keywords: buprenorphine; drug packaging; opioids; pediatric hospitalization; poisoning; prescription drugs; sulfonylureas; unintentional overdose.

Copyright © 2014 by the American Academy of Pediatrics.

PubMed Disclaimer

Conflict of interest statement

Potential Conflict of Interest disclosures: The authors have no conflicts of interest relevant to this article to disclose.

Figures

Figure 1

Figure 1. Estimated Rates of Emergency Hospitalizations for Unsupervised Oral Prescription Medication Ingestions by Children < 6 Years, United States, 2007–2011

Estimates of emergency hospitalizations for unsupervised oral prescription medication ingestions based on the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project, 2007–2011. Estimates of numbers of dispensed outpatient prescriptions and numbers of unique patients receiving dispensed prescriptions based on data from IMS Health, Vector One®, extracted August and September, 2013, respectively. aCoefficient of variation greater than 30%. bExcludes antitussive combination products.

Similar articles

Cited by

References

    1. Rodgers GB. The safety effects of child-resistant packaging for oral prescription drugs: two decades of experience. JAMA. 1996;275(21):1661–1665. - PubMed
    1. US Consumer Product Safety Commission. Poison prevention packaging: a guide for healthcare professionals. Washington, DC: US Consumer Product Safety Commission; 2005.
    1. Budnitz DS, Salis S. Preventing medication overdoses in young children: an opportunity for harm elimination. Pediatrics. 2011;127(6):e1597–e1599. - PubMed
    1. Bronstein AC, Spyker DA, Cantilena LR, Jr, Rumack BH, Dart RC. 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012;50(10):911–1164. - PubMed
    1. Bronstein AC, Spyker DA, Cantilena LR, Jr, Green JL, Rumack BH, Dart RC. 2010 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011;49(10):910–941. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources